Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality.

Shoshany O, Mano R, Margel D, Baniel J, Yossepowitch O.

Urol Oncol. 2014 Jan;32(1):40.e17-22. doi: 10.1016/j.urolonc.2013.04.009. Epub 2013 Aug 2.

PMID:
23911682
[PubMed - indexed for MEDLINE]
2.

Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.

Mariappan P, Finney SM, Head E, Somani BK, Zachou A, Smith G, Mishriki SF, N'Dow J, Grigor KM; Edinburgh Urological Cancer Group.

BJU Int. 2012 Jun;109(11):1666-73. doi: 10.1111/j.1464-410X.2011.10571.x. Epub 2011 Nov 1.

PMID:
22044434
[PubMed - indexed for MEDLINE]
3.

The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience.

Rouprêt M, Yates DR, Varinot J, Phé V, Chartier-Kastler E, Bitker MO, Compérat E.

Can J Urol. 2012 Oct;19(5):6459-64.

PMID:
23040628
[PubMed - indexed for MEDLINE]
4.

Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: is it a risk factor for residual tumor detection?

Süer E, Özcan C, Baltacı S, Gülpınar Ö, Burgu B, Haliloğlu A, Bedük Y.

Urol Int. 2013;91(2):182-6. doi: 10.1159/000350512. Epub 2013 Jun 6.

PMID:
23751593
[PubMed - indexed for MEDLINE]
5.

The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.

Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O'Donnell MA, Joudi FN.

BJU Int. 2009 Feb;103(4):475-9. doi: 10.1111/j.1464-410X.2008.08011.x. Epub 2008 Oct 6.

PMID:
18990174
[PubMed - indexed for MEDLINE]
6.

Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.

Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T; Cancer Registration Committee of the Japanese Urological Association.

Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.

PMID:
19207609
[PubMed - indexed for MEDLINE]
7.

Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.

Mariappan P, Zachou A, Grigor KM; Edinburgh Uro-Oncology Group.

Eur Urol. 2010 May;57(5):843-9. doi: 10.1016/j.eururo.2009.05.047. Epub 2009 Jun 6.

PMID:
19524354
[PubMed - indexed for MEDLINE]
8.

Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor.

Lee SE, Jeong IG, Ku JH, Kwak C, Lee E, Jeong JS.

Urology. 2004 May;63(5):873-7; discussion 877.

PMID:
15134968
[PubMed - indexed for MEDLINE]
9.

Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.

Chang WC, Chang YH, Pan CC.

Am J Surg Pathol. 2012 Mar;36(3):454-61. doi: 10.1097/PAS.0b013e31823dafd3.

PMID:
22261706
[PubMed - indexed for MEDLINE]
10.

The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.

Richterstetter M, Wullich B, Amann K, Haeberle L, Engehausen DG, Goebell PJ, Krause FS.

BJU Int. 2012 Jul;110(2 Pt 2):E76-9. doi: 10.1111/j.1464-410X.2011.10904.x. Epub 2012 Feb 7.

PMID:
22313727
[PubMed - indexed for MEDLINE]
11.

Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.

Ding W, Gou Y, Sun C, Xia G, Wang H, Chen Z, Tan J, Xu K, Qiang D.

Urol Oncol. 2014 Jan;32(1):42.e13-9. doi: 10.1016/j.urolonc.2013.05.004.

PMID:
24360660
[PubMed - indexed for MEDLINE]
12.

Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.

Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT.

J Urol. 2008 Nov;180(5):1928-32; discussion 1932. doi: 10.1016/j.juro.2008.07.056. Epub 2008 Sep 17.

PMID:
18801529
[PubMed - indexed for MEDLINE]
13.

Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.

Sternberg IA, Keren Paz GE, Chen LY, Herr HW, Dalbagni G.

BJU Int. 2013 Jul;112(1):54-9. doi: 10.1111/j.1464-410X.2012.11391.x. Epub 2012 Nov 13.

PMID:
23146082
[PubMed - indexed for MEDLINE]
14.

Analysis of the absence of the detrusor muscle in initial transurethral resected specimens and the presence of residual tumor tissue.

Huang J, Fu J, Zhan H, Xie K, Liu B, Yang F, Lu Y, Zhou X.

Urol Int. 2012;89(3):319-25. doi: 10.1159/000341103. Epub 2012 Aug 24.

PMID:
22922447
[PubMed - indexed for MEDLINE]
15.

Sensitivity to chemoradiation predicts development of metastasis in muscle-invasive bladder cancer patients.

Koga F, Numao N, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K.

Urol Oncol. 2013 Oct;31(7):1270-5. doi: 10.1016/j.urolonc.2012.01.014. Epub 2012 Mar 2.

PMID:
22386622
[PubMed - indexed for MEDLINE]
16.

Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.

Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.

Urol Oncol. 2013 Nov;31(8):1615-20. doi: 10.1016/j.urolonc.2012.03.004. Epub 2012 Apr 21.

PMID:
22521771
[PubMed - indexed for MEDLINE]
17.

[T1 high-grade bladder cancer - value of second operation with prognostuic parameters of first operation: analysis of 167 cases].

Lazica DA, Böttcher S, Degener S, von Rundstedt FC, Brandt AS, Roth S, Störkel S, Mathers MJ.

Aktuelle Urol. 2013 Mar;44(2):124-8. doi: 10.1055/s-0033-1334962. Epub 2013 Apr 11. German.

PMID:
23580383
[PubMed - indexed for MEDLINE]
18.

Predictive value of maspin and Ki-67 expression in transurethral resection specimens in patients with T1 bladder cancer.

Acikalin D, Oner U, Can C, Acikalin MF, Colak E.

Tumori. 2012 May-Jun;98(3):344-50. doi: 10.1700/1125.12403.

PMID:
22825520
[PubMed - indexed for MEDLINE]
19.
20.

Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.

Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, Chung J, Lee KH.

J Urol. 2009 Dec;182(6):2625-30. doi: 10.1016/j.juro.2009.08.083. Epub 2009 Oct 17.

PMID:
19836779
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk